Skip to main content
. 2015 Jul 7;10(3):1207–1211. doi: 10.3892/etm.2015.2622

Figure 2.

Figure 2.

Time dependence of the observed benefit (%) for (A) brachial artery flow-mediated dilation (FMD), and the (B) pulse wave velocity (PWV) and (C) β-stiffness values of the carotid artery with the initial treatment, during the rest period and with the current treatment. The treatment consisted of 1-month therapy with a low-dose fluvastatin and valsartan combination. The observed benefits were calculated with respect to the benefit of the initial treatment, which was considered as 100%.